HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Selective suppression of Th2 cell-mediated lung eosinophilic inflammation by anti-major facilitator super family domain containing 10 monoclonal antibody.

AbstractBACKGROUND:
The eosinophil is deeply associated with the pathogenesis of bronchial asthma and other allergic diseases. We recently identified a novel eosinophil-specific cell surface molecule, major facilitator super family domain containing 10 (Mfsd10). A monoclonal antibody (mAb) against Mfsd10 (M2) showed selective binding and neutralizing activities for eosinophils. However, the relative potency of the blockage of Mfsd10 and other eosinophil-specific molecules for the treatment of allergic diseases has not been evaluated. Therefore, in this study, the effects of M2 and an anti-Siglec-F mAb on antigen-immunized and antigen-specific Th2 cell-transferred murine eosinophilic inflammation models were comparatively investigated.
METHODS:
Ovalbumin (OVA)-specific Th2 cells were differentiated from naïve CD4+ T cells of DO11.10/RAG-2-/- mice in vitro and cytokine producing activity of the Th2 cells was examined. OVA-immunized and Th2 cell-transferred BALB/c mice were treated with M2 or anti-Siglec-F and challenged with OVA. Then the number of inflammatory cells and the concentration of IL-5 in the bronchoalveolar lavage fluid (BALF) were determined.
RESULTS:
Antigen-specific Th2 cells produced large amounts of IL-4, IL-5 and IL-13 but not IL-17A or IFN-γ. Administration of M2 significantly suppressed antigen-induced lung eosinophil infiltration both in OVA-immunized and Th2 cell-transferred mice. The potency as well as selectivity of M2 for down-regulating eosinophils was quite similar to that of anti-Siglec-F. Both mAbs did not affect antigen-induced IL-5 production in the lungs.
CONCLUSIONS:
Mfsd10 as well as Siglec-F could be an effective target to treat eosinophil-related disorders including bronchial asthma.
AuthorsTomoe Nishimura, Mayumi Saeki, Yuji Motoi, Noriko Kitamura, Akio Mori, Osamu Kaminuma, Takachika Hiroi
JournalAllergology international : official journal of the Japanese Society of Allergology (Allergol Int) Vol. 63 Suppl 1 Pg. 29-35 (May 2014) ISSN: 1440-1592 [Electronic] England
PMID24809373 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Differentiation, Myelomonocytic
  • Immunosuppressive Agents
  • Interleukin-5
  • Membrane Proteins
  • Mfsd10 protein, mouse
  • Sialic Acid Binding Immunoglobulin-like Lectins
  • Siglecf protein, mouse
Topics
  • Animals
  • Antibodies, Monoclonal (immunology, pharmacology)
  • Antigens, Differentiation, Myelomonocytic (immunology)
  • Disease Models, Animal
  • Eosinophils (immunology)
  • Female
  • Immunosuppressive Agents (pharmacology)
  • Interleukin-5 (biosynthesis)
  • Lymphocyte Activation (immunology)
  • Membrane Proteins (antagonists & inhibitors, immunology)
  • Mice
  • Mice, Knockout
  • Pulmonary Eosinophilia (drug therapy, genetics, immunology, pathology)
  • Sialic Acid Binding Immunoglobulin-like Lectins
  • Th2 Cells (immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: